Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Partial Period · Jun 1, 2026 — Sep 4, 2026
Partial Period · Jun 1, 2026 — Sep 4, 2026
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | INCY | ABBV | AMGN |
|---|---|---|---|
| Return | |||
| Last Price | 126.75 | 256.46 | 437.23 |
| Daily Change | − 0.98% | − 1.44% | − 1.55% |
| Period ReturnPast 3 Months | + 33.69% | + 20.44%Jun 1, 2026 — Sep 4, 2026 | + 32.84%Jun 1, 2026 — Sep 4, 2026 |
| Valuation | |||
| Market Cap | $25.7 B | $453 B | $236 B |
| P/E Ratio | — | 72.05 | — |
| Dividend Yield | — | 4.47% | — |
| Net MarginTrailing 12M | — | 9.8% | — |
| Risk | |||
| Beta | — | 0.20 | — |
| 52-Week Range | — | 190.75 — $267.47 | — |
| Company | |||
| Sector | Health Care | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- INCYHealth Care · Biotechnology
- ABBVHealth Care · Biotechnology
- AMGNHealth Care · Biotechnology
Metrics could not be loaded for INCY, AMGN: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 23:00
To Understand This